Daniel A Godefrooij1, G Ardine de Wit2, Cuno S Uiterwaal3, Saskia M Imhof4, Robert P L Wisse4. 1. Utrecht Cornea Research Group, Department of Ophthalmology, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: d.a.godefrooij@umcutrecht.nl. 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands; National Institute for Public Health and the Environment, Bilthoven, Netherlands. 3. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands. 4. Utrecht Cornea Research Group, Department of Ophthalmology, University Medical Center Utrecht, Utrecht, Netherlands.
Abstract
PURPOSE: To determine the age-specific incidence and prevalence of keratoconus in the modern era of diagnostics. DESIGN: Epidemiologic study. PARTICIPANTS: Total of 4.4 million patients from a mandatory health insurance database. METHODS: Data were extracted from the largest health insurance provider in the Netherlands. Patients aged 10-40 years were defined as the relevant age category for newly diagnosed keratoconus and the annual incidence of newly diagnosed keratoconus was determined. The prevalence of keratoconus was estimated based on the annual incidence, mean age at diagnosis, and average life expectancy. Main outcome measure was the annual incidence and prevalence of keratoconus. RESULTS: The annual incidence of keratoconus was 1:7500 in the relevant age category (13.3 cases per 100 000, 95% confidence interval [CI]: 11.6-15.2) and the estimated prevalence of keratoconus in the general population was 1:375 (265 cases per 100 000, 95% CI: 260-270). These values are 5-fold to 10-fold higher than previously reported values in population studies. The mean age at diagnosis was 28.3 years and 60.6% of diagnosed patients were male. CONCLUSIONS: Both the annual incidence and the prevalence of keratoconus were 5-fold to 10-fold higher than previously reported.
PURPOSE: To determine the age-specific incidence and prevalence of keratoconus in the modern era of diagnostics. DESIGN: Epidemiologic study. PARTICIPANTS: Total of 4.4 million patients from a mandatory health insurance database. METHODS: Data were extracted from the largest health insurance provider in the Netherlands. Patients aged 10-40 years were defined as the relevant age category for newly diagnosed keratoconus and the annual incidence of newly diagnosed keratoconus was determined. The prevalence of keratoconus was estimated based on the annual incidence, mean age at diagnosis, and average life expectancy. Main outcome measure was the annual incidence and prevalence of keratoconus. RESULTS: The annual incidence of keratoconus was 1:7500 in the relevant age category (13.3 cases per 100 000, 95% confidence interval [CI]: 11.6-15.2) and the estimated prevalence of keratoconus in the general population was 1:375 (265 cases per 100 000, 95% CI: 260-270). These values are 5-fold to 10-fold higher than previously reported values in population studies. The mean age at diagnosis was 28.3 years and 60.6% of diagnosed patients were male. CONCLUSIONS: Both the annual incidence and the prevalence of keratoconus were 5-fold to 10-fold higher than previously reported.
Authors: Robert P L Wisse; Rob W P Simons; Martijn J B van der Vossen; Marc B Muijzer; Nienke Soeters; Rudy M M A Nuijts; Daniel A Godefrooij Journal: JAMA Ophthalmol Date: 2019-06-01 Impact factor: 7.389
Authors: Uri Simcha Soiberman; Ahmed Elsayed Mahmoud Shehata; Michelle Xiaoyi Lu; Tempest Young; Yassine J Daoud; Shukti Chakravarti; Albert S Jun; James William Foster Journal: Invest Ophthalmol Vis Sci Date: 2019-08-01 Impact factor: 4.799
Authors: Brecken J Blackburn; Shi Gu; Matthew R Ford; Vinícius de Stefano; Michael W Jenkins; William J Dupps; Andrew M Rollins Journal: Invest Ophthalmol Vis Sci Date: 2019-01-02 Impact factor: 4.799
Authors: Vishal Shinde; Nara Sobreira; Elizabeth S Wohler; George Maiti; Nan Hu; Giuliana Silvestri; Sonia George; Jonathan Jackson; Aravinda Chakravarti; Colin E Willoughby; Shukti Chakravarti Journal: Hum Mol Genet Date: 2021-05-17 Impact factor: 6.150